Video to Promote HPV Vaccination
- Conditions
- Acceptance ProcessesHuman PapillomavirusSocial AcceptanceHealth BehaviorVaccine Acceptance
- Interventions
- Other: Educational Video with Male or Female Narrator
- Registration Number
- NCT02196454
- Lead Sponsor
- Children's Hospital of Philadelphia
- Brief Summary
The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.
- Detailed Description
Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens.
Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 110
- Parent-child dyads in which the child is a male or female age 11 to 17 years who has not received the HPV vaccine
- Parent-child dyads in which the child has received the HPV vaccine
- Parent-child dyads in which the child is older than 18 at the time of enrollment
- Non-English speakers
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Video & Vaccine Information Statement Educational Video with Male or Female Narrator Participants will view an educational video about the HPV vaccine with a male or female narrator. Participants will also receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
- Primary Outcome Measures
Name Time Method HPV Vaccine Series Initiation 0 days HPV Vaccine Receipt among study participants
HPV Vaccination Series Initiation 90 days Number of HPV vaccine doses received among study participants
- Secondary Outcome Measures
Name Time Method HPV Vaccine Series Initiation (depending on male versus female narrator) 90 days Difference in number of HPV vaccine doses between study participants who viewed a video narrated by a male versus a female
Trial Locations
- Locations (2)
Primary Care, Flourtown, Children's Hospital of Philadelphia
🇺🇸Flourtown, Pennsylvania, United States
Nicholas and Athena Karabots Pediatric Care Center
🇺🇸Philadelphia, Pennsylvania, United States